BN · rank #20 · 2026-10-23
AXON
NASDAQ · $32.71B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of the factors below; drives the rank. | -0.01 |
|---|---|
| Forward revenue growth Consensus forward revenue growth. | +29.3% |
| Forward net margin Consensus forward net margin. | +6.6% |
| Net margin TTM Trailing twelve month net margin. | +6.2% |
| Margin expansion Forward minus trailing net margin (percentage points). | +0.4% |
| Forward PEG Forward P/E to growth. Below 1 is cheap for the growth. | 2.11 |
| Debt / FCF Net debt relative to free cash flow. Lower is safer. | 13.77× |
| Analyst upside Spread between the consensus 12m target and the current price. | +64.4% |
| Last EPS surprise Most recent reported EPS versus consensus. | +90% |
| Market cap (USD) | $32.71B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
Axon Enterprise provides an integrated public-safety ecosystem encompassing TASER conducted-energy devices, body and in-car cameras, counter-drone systems, and cloud-based digital evidence management software.
Rationale
Axon validates the bottleneck-solver thesis by controlling the critical workflow nexus between law enforcement hardware capture and digital evidence storage, backed by 29%+ forward revenue growth and a $15.1 billion contracted backlog.
Material risks
- 1Motorola Solutions and specialized vendors like Anduril, Skydio, and Flock could displace Axon in newer drone, counter-drone, and AI dispatch categories where Axon lacks its core TASER sole-source protection.
- 2Cash conversion challenges from inventory build and billing schedules drove negative Q2 free cash flow, while the $1.15 billion zero-coupon convertible issuance adds balance sheet leverage and potential future dilution.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.